$0.8510
-0.0023-0.27%
Ult. Agg.: Oct 1, 6:18 PM
$0.8320
-0.0213-2.5%
Dare Bioscience (DARE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.30 | $-0.31 | $-0.35 | $-0.36 |
| Actual | $-0.20 | $-0.20 | $-0.02 | $-0.28 |
| Surprise | +33.3% | +35.5% | +94.3% | +22.2% |
| Revenue | ||||
| Estimate | $2000 | $601600 | $1.0M | $21850 |
| Actual | $187546 | $152455 | $1.0M | $2262 |
| Surprise | +9277.3% | -74.7% | -0.68% | -89.6% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.23 | $-0.07 | $-0.10 |
| Revenue | ||||
| Consensus | $2.8M | $467464 | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.20 | $-0.30 | 33.3 % |
| Q1 | May 14, 2026 | $-0.20 | $-0.31 | 35.5 % |
| Q4 | Mar 26, 2026 | $-0.02 | $-0.35 | 94.3 % |
| Q3 | Nov 13, 2025 | $-0.28 | $-0.36 | 22.2 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $187.55K | $2.00K | 9277.3 % |
| Q1 | May 14, 2026 | $152.46K | $601.60K | -74.7 % |
| Q4 | Mar 26, 2026 | $1.02M | $1.03M | -0.68 % |
| Q3 | Nov 13, 2025 | $2.26K | $21.85K | -89.6 % |